A Non-covalent Peptide-Based Strategy for Ex Vivo and In Vivo Oligonucleotide Delivery

Methods in Molecular Biology

Volumn 764, Issue , 2011, Pages 59-73

  Crombez, Laurence ^a   Morris, May C ^a   Heitz, Frederic ^a   Divita, Gilles ^a  

^a Centre National de la Recherche Scientifique   (France)

Author keywords

amphiphatic peptide; cancer mouse models; Cell penetrating peptide; drug delivery; non endosomal pathway; peptide acid nucleic; peptide based non covalent strategy; sirna

Indexed keywords

CELL PENETRATING PEPTIDE; CYCLIN B1; MACROGOL DERIVATIVE; MESSENGER RNA; MPG 8 PEPTIDE; MPG-8 PEPTIDE; NANOPARTICLE; OLIGONUCLEOTIDE; OLIGOPEPTIDE; PEP 3 PEPTIDE; PEP-3 PEPTIDE; PEPTIDE; PEPTIDE NUCLEIC ACID; RNA BINDING PROTEIN; SMALL INTERFERING RNA;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL ADHESION; CELL LINE; CHEMISTRY; DISEASE MODEL; DRUG DELIVERY SYSTEM; FEMALE; GENETIC TRANSFECTION; HUMAN; MALE; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MOUSE; NUDE MOUSE; PATHOLOGY; PROSTATE TUMOR; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANIMALS; CELL ADHESION; CELL LINE; CELL-PENETRATING PEPTIDES; CYCLIN B1; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NANOPARTICLES; OLIGONUCLEOTIDES; OLIGOPEPTIDES; PEPTIDE NUCLEIC ACIDS; PEPTIDES; POLYETHYLENE GLYCOLS; PROSTATIC NEOPLASMS; PROTEIN BINDING; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; TRANSFECTION;

EID: 79960936793     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-188-8_4     Document Type: Chapter

References (27)

1. Opalinska, J. B., and Gewirtz, A. M. (2002) Nucleic acid therapeutics: basis principles and recent application. Nat. Rev. Drug Discov. 1, 503–514.
2. Sazani, P., Vacek, M. M., and Kole, R. (2002) Short-term and long-term modulation of gene expression by antisense therapeutics. Curr. Opin. Biotechnol. 13, 468–472.
3. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., and Mello, C. C. (1988) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806–811.
4. Dorsett, Y., and Tuschl, T. (2004) siR-NAs: applications in functional genomics and potential as therapeutics. Nat. Rev. Drug Discov. 3, 318–329.
5. Castanotto, D., and Rossi, J. J. (2009) The promises and pitfalls of RNA-interference-based therapeutics. Nature 457, 426–433.
6. Nielsen, P. E., and Egholm, M. (1999) Introduction to peptide nucleic acid. Curr. Issues Mol. Biol. 1, 89–104.
7. Nielsen, P. E. (2006) Addressing the challenges of cellular delivery and bioavailability of peptide nucleic acids (PNA). Q. Rev. Biophys. 38, 345–350.
8. Egholm, M., Buchardt, O., Christensen, L., Behrens, C., Freier, S. M., Driver, D. A., Berg, R. H., Kim, S. K., Norden, B., and Nielsen, P. E. (1993) PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature 365, 566–568.
9. De Fougerolles, A., Vornlocher, H.-P., Maraganore, J., and Lieberman, J. (2007) Interfering with disease: a progress report on siRNA-based therapeutics. Nat. Rev. Drug Discov. 6, 443–453.
10. Whitehead, K. A., Langer, R., and Anderson, D. G. (2009) Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov. 8, 129–138.
11. Sibley, C. R., Seow, Y., and Wood, M. J. (2010) Novel RNA-based strategies for therapeutic gene silencing. Mol. Ther. 18, 466–476.
12. Juliano, R., Alam, M. R., Dixit, V., and Kang, H. (2008) Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res. 36, 4158–4171.
13. Heitz, F., Morris, M. C., and Divita, G. (2009) Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br. J. Pharmacol. 157, 195–206.
14. Eguchi, A., and Dowdy, S. F. (2009) siRNA delivery using peptide transduction domains. Trends Pharmacol. Sci. 30, 341–345.
15. El-Andaloussi, S., Holm, T., and Langel, U. (2005) Cell-penetrating peptides: mech-anisms and applications. Curr. Pharm. Des. 11, 3597–3611.
16. Pooga, M., Soomets, U., Hallbrink, M., Valkna, A., Saar, K., Rezaei, K., Kahl, U., Hao, J. X., Xu, X. J., Wiesenfeld-Hallin, Z., Hokfelt, T., Bartfai, T., and Langel, U. (1998) Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 16, 857–861.
17. Lebleu, B., Moulton, H. M., Abes, R., Ivanova, G. D., Abes, S., Stein, C. A., Iversen, P. L., Arzumanov, A. A., and Gait, M. J. (2008) Cell penetrating peptide conjugates of steric block oligonucleotides. Adv. Drug Deliv. Rev. 60, 517–529.
18. Said Hassane, F., Saleh, A. F., Abes, R., Gait, M. J., and Lebleu, B. (2010) Cell penetrating peptides: overview and applications to the delivery of oligonucleotides. Cell Mol. Life Sci. 67, 715–26.
19. Crombez, L., Morris, M. C., Deshayes, S., and Divita, G. (2008) Peptide-based Nanoparticles for ex vivo and in vivo drug delivery. Curr. Pharm. Des. 14, 3656–3665.
20. Simeoni, F., Morris, M. C., Heitz, F., and Divita, G. (2003) Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res. 31, 2717–2724.
21. Zeineddine, D., Papadimou, E., Chebli, K., Gineste, M., Liu, J., Grey, C., Thurig, S., Behfar, A., Wallace, V. A., Skerjanc, I. S., and Puceat, M. (2006) Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development. Dev. Cell 11, 535–546.
22. Crombez, L., Morris, M. C., Dufort, S., Aldrian-Herrada, G., Nguyen, Q., Mc Master, G., Coll, J. L., Heitz, F., and Divita, G. (2009) Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth. Nucleic Acids Res. 37, 4559–4569.
23. Morris, M. C., Gros, E., Aldrian-Herrada, G., Choob, M., Archdeacon, J., Heitz, F., and Divita, G. (2007) A non-covalent peptide-based carrier for in vivo delivery of DNA mimics. Nucleic Acids Res. 35, e49–e59.
24. Morris, M. C., Depollier, J., Mery, J., Heitz, F., and Divita, G. (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19, 1173–1176.
25. Efimov, V., Choob, M., Buryakova, A., Phelan, D., and Chakhmakhcheva, O. (2001) PNA-related oligonucleotide mimics and their evaluation for nucleic acid hybridization studies and analysis. Nucleosides Nucleotides Nucleic Acids 20, 419–428.
26. Deshayes, S., Morris, M., Heitz, F., and Divita, G. (2008) Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv. Drug Deliv. Rev. 60, 537–547.
27. Umekita, Y., Hiipakka., R. A., Kokontis, J. M., and Liao, S. (1996) Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finas-teride. Proc. Natl. Acad. Sci. USA 93, 11802–11807.